Skip to content

Very Long-term (>15 Years) Results of Tricuspid Valve Repair.

Very Long-term (>15 Years) Results of Tricuspid Valve Repair.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05836493
Enrollment
146
Registered
2023-05-01
Start date
2020-10-07
Completion date
2020-10-23
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tricuspid Regurgitation

Brief summary

Interest in Tricuspid valve disease grew exponentially in the last years in response to an increased awareness of the poor outcome of patients with functional Tricuspid Regurgitation (TR). Earlier reports advocated for a more conservative TR management in patients undergoing left-sided heart valve surgery but more recent guidelines advised for a more aggressive TR management, as accumulating evidence demonstrates its adverse impact on long term morbidity and mortality. Several papers have been published analyzing the results of surgical tricuspid valve repair but the length of the follow-up is usually limited to 10 to 12 years. With this study the investigators aim to analyze the very long-term results (\>15years) of tricuspid valve repair according to the surgical method employed for valve repair (suture vs ring annuloplasty).

Interventions

PROCEDURERing annuloplasty

A prosthetic ring is implanted to treat tricuspid regurgitation

PROCEDURESuture procedure

Suture techniques such as Kay or De Vega are used to reduce tricuspid annulus in order to treat tricuspid regurgitation

Sponsors

Michele De Bonis
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* cardiac surgery treatment of TR, isolated or in conjunction with other procedures on the left heart * patients operated on between January 1998 and December 2004

Design outcomes

Primary

MeasureTime frame
Mortalitythrough study completion, a minimum of 15 years

Secondary

MeasureTime frame
Reinterventionthrough study completion, a minimum of 15 years
TR recurrencethrough study completion, a minimum of 15 years

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026